Her2 alterations in muscle-invasive bladder cancer: Patient selection beyond protein expression for targeted therapy

Although the introduction of novel targeted agents has improved patient outcomes in several human cancers, no such advance has been achieved in muscle-invasive bladder cancer (MIBC). However, recent sequencing efforts have begun to dissect the complex genomic landscape of MIBC, revealing distinct mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Kiss, Bernhard, Wyatt, Alexander W., Douglas, James, Skuginna, Veronika, Mo, Fan, Anderson, Shawn, Rotzer, Diana, Fleischmann, Achim, Genitsch, Vera, Hayashi, Tetsutaro, Neuenschwander, Maja, Buerki, Christine, Davicioni, Elai, Collins, Colin, Thalmann, George N., Black, Peter C., Seiler, Roland
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5311866/
https://www.ncbi.nlm.nih.gov/pubmed/28205537
http://dx.doi.org/10.1038/srep42713

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5311866/
https://www.ncbi.nlm.nih.gov/pubmed/28205537
http://dx.doi.org/10.1038/srep42713

Ejemplares similares